SBFM earnings
Sunshine Biopharma (SBFM) next earnings date and estimates, and its past reports: EPS against estimates, the surprise and revenue.
- SBFM beat EPS estimates in 6 of its last 12 reports.
SBFM earnings history
| Quarter | Reported | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|---|
| Q3 2026 | Nov 12, 2026 | -5.20 | -3.40 | -52.94% | $9.44M |
| Q2 2026 | Aug 13, 2026 | -23.00 | -24.00 | 4.17% | $9.26M |
| Q1 2026 | May 13, 2026 | -2.50 | -1.60 | -56.25% | $8.09M |
| Q1 2026 | Apr 4, 2026 | -3.00 | -2.70 | -11.11% | $8.09M |
| Q3 2025 | Nov 13, 2025 | -1.90 | -1.30 | -46.15% | $9.42M |
| Q2 2025 | Aug 12, 2025 | -3.90 | -1.10 | -254.55% | $9.41M |
| Q1 2025 | May 15, 2025 | -4.40 | – | – | $8.90M |
| Q3 2024 | Nov 5, 2024 | -9.40 | -5350.00 | 99.82% | $8.44M |
| Q2 2024 | Aug 16, 2024 | -1988.00 | -148.00 | -1243.24% | $9.30M |
| Q1 2024 | May 20, 2024 | -400.00 | -3200.00 | 87.50% | $7.54M |
| Q4 2023 | Mar 28, 2024 | -1000.00 | -1200.00 | 16.67% | $7.68M |
| Q3 2023 | Nov 13, 2023 | -800.00 | -2400.00 | 66.67% | $5.96M |
| Q2 2023 | Aug 11, 2023 | -400.00 | -3200.00 | 87.50% | $5.56M |
| Q1 2023 | May 10, 2023 | -1600.00 | – | – | $4.89M |
| Q1 2023 | Apr 4, 2023 | -30000.00 | – | – | $4.89M |
| Q3 2022 | Nov 7, 2022 | -1600.00 | – | – | $132.81K |